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Review question/objective
The objective of this review is to determine the best available evidence related to the effect of insulin
therapy algorithms on blood glucose levels in patients in critical care environments following cardiac
surgery.
More specifically, the review question to be answered is:
Among adults within critical care environments who are in the acute postoperative phase (5 days)
following cardiac surgery, what is the effect of insulin therapy algorithms for the control of blood glucose
levels?

Background
Hyperglycemia, a condition characterized by elevated blood glucose levels (BGLs), is most commonly
1

associated with diabetic illness. However, hyperglycemia has also been found to have a high incidence
after cardiac surgery. Current literature surrounding this topic suggests that hyperglycemia occurs
almost universally after cardiac surgery; irrespective of whether a person has a pre-existing diagnosis of
diabetes mellitus or not.

1-3

Conventionally, post-operative hyperglycemia following cardiac surgery was

viewed purely as a natural adaptive physiological response of the body that was treated only when
2

BGLs rose to what was considered excessively high levels; generally greater than 12.2 mmol/L
4

[220mg/dl]. This view has since changed and hyperglycemia following cardiac surgery is now viewed
as an adverse effect of surgery, occurring as a result of multiple factors that include: the intraoperative
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hypothermic state, surgical stress, hypokalemia, adverse effects from pharmacological agents and the
commonly occurring post-operative systemic inflammatory response.

5-7

While generally only transient, an incidence of hyperglycemia during the initial post-operative period
can have serious detrimental side effects following cardiac surgery such as deep sternal wound
8

infection and an increased risk of mortality. Current evidence suggests that within critical care
environments, the early recognition and treatment of post-operative hyperglycemia is imperative. This is
achieved through the utilization of continuous intravenous insulin infusion algorithms, with the aim of
maintaining BGLs within normal to near normal ranges, in order to prevent the adverse outcomes
associated with hyperglycemia in post-operative patients.

9

The practice of maintaining BGLs within strict pre-defined levels, via the administration and titration of a
continuous insulin infusion, has become common practice within critical care environments over the
past decade.

10

Results from a study by Van Den Berghe et al., which included 970 cardiac surgery

patients [63%] showed that the maintenance of BGLs below 110 mg/dl [6.1 mmol/L], using continuous
insulin therapy lead to decreases in both mortality and morbidity rates among critically ill surgical
3

patients. Since this time, multiple studies investigating the effects of continuous insulin infusion
algorithms have concluded that the use of such algorithms for the management of BGLs in cardiac
surgery patients has favorable effects, decreasing the incidence of post-operative complications and
reducing the length of time patients are required to remain in hospital.

11

The use of continuous intravenous infusion algorithms for controlling BGLs in critically ill patients is
further supported by the American Diabetes Association [ADA] who recommend the use of tried and
tested insulin infusion protocols that demonstrate a low incidence of hypoglycemia.

12

The ADA go on to

state that BGLs of critically ill patients, including postoperative patients who have undergone a cardiac
procedure, should be maintained between 7.8 and 10 mmol/L [140 and 180mg/dl] with insulin therapy
12

commenced at a threshold no higher than 10 mmol/L [180mg/dl]. While it is acknowledged that greater
benefits may be achieved by the maintenance of BGLs at the lower ends of the range, the American
Diabetes Association do not recommend targets less than 6.1mmol/l [110mg/l] due the high risk of
causing significant hypoglycemia.

12

A review of the literature shows that a number of insulin infusion algorithms, with varying methods and
effects, have been developed for utilization by clinicians in critical care environments to guide the
management of hyperglycemia. Due to the conflicting evidence that currently exists, the critical care
clinician responsible for the provision of care to post-operative cardiac surgery patients needs to
determine the best evidence in relation to the management of hyperglycemia, to maintain patient safety
and ensure good surgical outcomes, free from complications. However, a review of the outcomes of
these protocols for cardiac patients has not been published to inform the development of best evidence
based practice guidelines. This systematic review therefore aims to review the various protocols to
ascertain the best available evidence related to the effect of intensive insulin therapy algorithms on
BGLs in post-operative patients in critical care environments following cardiac surgery.

Keywords
Hyperglycemia/hyperglycaemia; Blood glucose; Cardiac surgery; Heart surgery; Insulin; Insulin
infusion; Intensive insulin infusion; Intravenous insulin infusion; Continuous insulin infusion;
Postoperative; Critical care environment
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Inclusion criteria
Types of participants
This review will consider studies that include adult patients aged 18 years and over admitted to a critical
care unit following cardiac surgery and who received insulin therapy for glycemic control during the
acute postoperative phase (five days) of admission.
In this review studies that include participants with a known diagnosis of Diabetic Ketoacidosis will be
excluded.
Types of intervention(s)/phenomena of interest
This review will consider studies that evaluate the use of intravenous insulin therapy algorithms to
control blood glucose levels in acute postoperative phase patients in critical care environments
following cardiac surgery.
In this review, studies will be included if they make one of the following comparisons:
1. Intravenous insulin therapy algorithm compared to another insulin therapy algorithm.
2. Intravenous insulin therapy algorithm compared to no treatment.
3. Intravenous insulin therapy algorithm compared to a placebo.
In this review, studies that include a Glucose-Insulin-Potassium (GIK) infusion as an intervention or a
comparator will be excluded.
Types of outcomes
This review will consider studies that include the following outcome measures:
Primary outcome:


Overall control of blood glucose levels as measured by time to target BGL range, time spent in
BGL target range and time above or below target BGL range.

Secondary outcome:



Incidence of adverse events, including:
- Hypo/hyper glycemia, measured by standard point of care glucometers, arterial blood
analysis, or venous blood analysis, with hypoglycemia defined as a BGL reading <3.9mmol/L
(70mg/dL)

13

13

and hyperglycemia defined as a BGL reading >7.8mmol/L(140mg/dL).

- Sternal wound infection, identified by a positive wound culture or a positive wound exudate
14

culture.

- Mortality rate measured by in-hospital mortality (from day of operation to day of discharge)
15

and/or 30 day mortality.
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Types of studies
This review will consider any experimental study design including randomized controlled trials,
non-randomized controlled trials, quasi-experimental and before and after studies for inclusion.

Search strategy
The search strategy aims to find both published and unpublished studies. A three-step search strategy
will be utilized in this review. An initial limited search of MEDLINE and CINAHL will be undertaken,
followed by analysis of the text words contained in the title and abstract and of the index terms used to
describe the article. A second search using all identified keywords and index terms will then be
undertaken across all included databases. Thirdly, the reference lists of all identified reports and articles
will be hand searched for additional studies.
Studies published in the English language will be considered for inclusion in this review. Databases will
be searched with no limits placed on the date of publication, allowing authors to search as far back as
possible.
The databases to be searched include:
MEDLINE, CINAHL, PubMed, Embase, SCOPUS, Cochrane Trials, Dare, Social Science Index.
The search for unpublished studies will include:
ProQuest Dissertations & Theses and MedNar
Initial keywords to be used will be:
Hyperglycemia/hyperglycaemia
Blood glucose
Cardiac surgery
Heart surgery
Insulin
Insulin infusion
Intensive insulin infusion
Intravenous insulin infusion
Continuous insulin infusion
Postoperative
Critical care environment

Assessment of methodological quality
Papers selected for retrieval will be assessed by two independent reviewers for methodological validity
prior to inclusion in the review using standardized critical appraisal instruments from the Joanna Briggs
Institute Meta-Analysis of Statistics Assessment and Review Instrument (JBI-MAStARI) (Appendix I).
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Any disagreements that arise between the reviewers will be resolved through discussion, or with a third
reviewer.

Data collection
Data will be extracted from papers included in the review using the standardized data extraction tool
from JBI-MAStARI (Appendix II). The data extracted will include specific details about the interventions,
populations, study methods and outcomes of significance to the review question and specific
objectives.

Data synthesis
Quantitative data will, where possible, be pooled in statistical meta-analysis using JBI-MAStARI. All
results will be subject to double data entry. Effect sizes expressed as odds ratios (for categorical data)
and weighted mean differences (for continuous data) and their 95% confidence intervals will be
calculated for analysis. Heterogeneity will be assessed statistically using the standard Chi-square and
also explored using subgroup analyses based on the different study designs included in this review.
Where statistical pooling is not possible, the findings will be presented in narrative form including tables
and figures to aid in data presentation where appropriate.
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Appendix I: Appraisal instruments
MAStARI appraisal instrument
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Appendix II: Data extraction instruments
MAStARI data extraction instrument
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